The Beijing Saiaojin Tumor Hospital International Alliance serves as the core strategic platform for the Sino-US Saiaojin Tumor Chain Group, facilitating nationwide expansion and international connectivity. Supported by cutting-edge biomedical technology and backed by an internationalized diagnosis and treatment system, the alliance is dedicated to precision oncology and innovative cell therapy, striving to establish an international oncology medical hub that integrates clinical practice, scientific research, and translational research.